Steve N. Slilaty Sunshine Biopharma, Inc. (SBFM) insider trading activity
Steve N. Slilaty is Chief Executive Officer of Sunshine Biopharma, Inc.. Currently has a direct ownership of 130,000 shares of SBFM, which is worth approximately $370,500. The most recent transaction as insider was on Mar 04, 2024, when has been sold 100,000 shares (Series B Preferred Stock) at a price of $0.1 per share, resulting in proceeds of $10,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
130K
0%
3M change
n/a
12M change
Total Value Held
$370,500
Steve N. Slilaty Transaction History
SNS
Steve N. Slilaty
Chief Executive Officer
New York, NY